Crinetics Pharmaceuticals, Inc. (CRNX) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
CRNX currently has 104M outstanding shares. with minimal authorized share overhang for future dilution. The company has significantly diluted shareholders by 29.45% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 07, 2026 |
10-Q filing | 104.1M shares outstanding |
100M | 0 |
| Nov 06, 2025 |
10-Q filing | 94.2M shares outstanding |
94M | 0 |
| Aug 07, 2025 |
10-Q filing | 93.8M shares outstanding |
94M | 0 |
| May 08, 2025 |
10-Q filing | 93.1M shares outstanding |
93M | 0 |
| Feb 27, 2025 |
10-K filing | 93.0M shares outstanding |
93M | 0 |
| Nov 12, 2024 |
10-Q filing | 92.7M shares outstanding |
93M | 0 |
| Aug 08, 2024 |
10-Q filing | 79.0M shares outstanding |
79M | 0 |
| May 09, 2024 |
10-Q filing | 72.3M shares outstanding |
72M | 0 |
| Feb 28, 2024 |
10-K filing | 69.6M shares outstanding |
70M | 0 |
| Nov 07, 2023 |
10-Q filing | 66.8M shares outstanding |
67M | 0 |
| Aug 08, 2023 |
10-Q filing | 54.3M shares outstanding |
54M | 0 |
| May 09, 2023 |
10-Q filing | 53.9M shares outstanding |
54M | 0 |
| Feb 28, 2023 |
10-K filing | 52.0M shares outstanding |
52M | 0 |
| Nov 14, 2022 |
10-Q filing | 53.8M shares outstanding |
54M | 0 |
| Aug 12, 2022 |
10-Q filing | 52.5M shares outstanding |
53M | 0 |
| May 12, 2022 |
10-Q filing | 53.5M shares outstanding |
54M | 0 |
| Mar 30, 2022 |
10-K filing | 47784.6M shares outstanding |
48B | 0 |
| Nov 05, 2021 |
10-Q filing | 47.5M shares outstanding |
47M | 0 |
| Oct 18, 2021 |
8-K filing: Crinetics Pharmaceuticals, Inc. announced the formation of Radionetics Oncology, Inc. and received 50,500,000 shares of common stock of Radionetics, representing a 50.5% equity stake, and a warrant to purchase additional shares to maintain at least 22% equity interest; Radionetics also completed a $30 million private financing. |
39M | 0 |
| Aug 10, 2021 |
10-Q filing | 38.6M shares outstanding |
39M | 0 |
| May 06, 2021 |
10-Q filing | 37.6M shares outstanding |
38M | 0 |
| Mar 30, 2021 |
10-K filing | 33.0M shares outstanding |
33M | 0 |
| Nov 06, 2020 |
10-Q filing | 32.9M shares outstanding |
33M | 0 |
| Aug 07, 2020 |
10-Q filing | 32.9M shares outstanding |
33M | 0 |
| May 08, 2020 |
10-Q filing | 32.8M shares outstanding |
33M | 0 |
| Mar 09, 2020 |
10-K filing | 24.6M shares outstanding |
25M | 0 |